Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
4D Molecular Therapeutics (FDMT)
- 10.060
- +0.290+2.97%
Close Apr 16 16:00 ET
- 10.004
- -0.056-0.56%
Post 18:46 ET
513.58MMarket Cap-4.16P/E (TTM)
10.100High9.530Low837.07KVolume9.750Open9.770Prev Close8.21MTurnover2.37%Turnover RatioLossP/E (Static)51.05MShares12.34052wk High1.02P/B354.72MFloat Cap2.96052wk Low--Dividend TTM35.26MShs Float55.110Historical High--Div Yield TTM5.83%Range %2.235Historical Low9.811Avg Price1Lot Size
4D Molecular Therapeutics (FDMT) Key Financial Indicators
FDMT Earnings per Share (EPS)
According to the latest financial report of 4D Molecular Therapeutics, the latest earnings per share (TTM) for the company is 0.43. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FDMT Free Cash Flow (FCF)
Interested in knowing about 4D Molecular Therapeutics's free cash flow? The latest report shows it as 28.62M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
FDMT Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of 4D Molecular Therapeutics shows that the company's current ratio is 9.39, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
FDMT Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of 4D Molecular Therapeutics, the quick ratio is 9.15, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
FDMT Return on Equity (ROE)
Want to learn more about the financial health of 4D Molecular Therapeutics? The latest ROE figure is 4.44%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
FDMT Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of 4D Molecular Therapeutics, the total asset return on investment (ROA) is 3.92%.
Currency: USD
Quarterly
Loading...
FDMT Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check 4D Molecular Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
FDMT Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of 4D Molecular Therapeutics, the net profit margin is 22.80%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm